Fresenius Medical Care AG & Co. KGaA (FMS)
NYSE: FMS · IEX Real-Time Price · USD
19.69
-0.28 (-1.40%)
At close: Jul 19, 2024, 4:00 PM
19.75
+0.06 (0.30%)
Pre-market: Jul 22, 2024, 7:02 AM EDT
FMS Market Cap
FMS has a market cap or net worth of $11.55 billion as of July 22, 2024. Its market cap has decreased by -15.96% in one year.
Market Cap
11.55B
Enterprise Value
25.75B
1-Year Change
-15.96%
Ranking
Category
Stock Price
$19.69
Market Cap Chart
Since December 1, 1998, FMS's market cap has increased from $5.99B to $11.55B, an increase of 93.01%. That is a compound annual growth rate of 2.60%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 11.55B | -5.47% |
Dec 29, 2023 | 12.22B | 27.48% |
Dec 30, 2022 | 9.59B | -49.57% |
Dec 31, 2021 | 19.01B | -23.32% |
Dec 31, 2020 | 24.80B | 9.70% |
Dec 31, 2019 | 22.60B | 13.87% |
Dec 31, 2018 | 19.85B | -38.32% |
Dec 29, 2017 | 32.18B | 24.87% |
Dec 30, 2016 | 25.77B | 2.18% |
Dec 31, 2015 | 25.23B | 12.65% |
Dec 31, 2014 | 22.39B | 3.94% |
Dec 31, 2013 | 21.54B | 4.62% |
Dec 31, 2012 | 20.59B | 1.55% |
Dec 30, 2011 | 20.28B | 18.85% |
Dec 31, 2010 | 17.06B | 9.93% |
Dec 31, 2009 | 15.52B | 12.36% |
Dec 31, 2008 | 13.81B | -10.15% |
Dec 31, 2007 | 15.37B | 64.77% |
Dec 29, 2006 | 9.33B | 131.35% |
Dec 31, 2002 | 4.03B | -31.05% |
Dec 31, 2001 | 5.85B | -26.55% |
Dec 29, 2000 | 7.96B | -4.19% |
Dec 31, 1999 | 8.31B | 20.77% |
Dec 31, 1998 | 6.88B | 14.97% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Royalty Pharma | 12.72B |
Smith & Nephew | 12.33B |
Insmed | 12.25B |
DaVita | 12.10B |
Bio-Techne | 11.89B |
Charles River Laboratories International | 11.24B |
Universal Health Services | 10.79B |
Legend Biotech | 10.71B |